Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07120711) titled 'EGR2 and NLRP3 Pathways in Obstructive Sleep Apnea-Related Cognitive and Mood Disorders' on Aug. 7.
Study Type: Observational
Primary Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
Obstructive Sleep Apnea-Hypopnea Syndrome
Anxiety Disorders
Depressive Disorders
Intervention:
Procedure: EGR2/NLRP3 pathway activity
Recruitment Status: Recruiting
Date of First Enrollment: July 1, 2025
Target Sample Size: 1000
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07120711
Published by HT Digital Content Services with permission from ...